Lenalidomide hemihydrate
| CAS No. | 847871-99-2 | Cat. No. | BCP25399 |
| Name | Lenalidomide hemihydrate | ||
| Synonyms | CC-5013 hemihydrate;CC 5013 hemihydrate;CC5013 hemihydrate; | ||
| Formula | C26H28N6O7 | M. Wt | 536.55 |
| Description | Lenalidomide hemihydrate, a derivative of Thalidomide, acts as molecular glue. Lenalidomide hemihydrate is an orally active immunomodulator. Lenalidomide hemihydrate is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide hemihydrate (CC-5013 hemihydrate) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells. | ||
| Pathways | Others Pathway | ||
| Targets | PROTAC | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.